Cihat Unlu*, M.D. Batuhan Ozmen**, M.D. Ankara, Turkey. Comment by:
|
|
- Alannah Fields
- 5 years ago
- Views:
Transcription
1 4. Van Voorhis BJ, Barnett M, Sparks AE, Syrop CH, Rosenthal G, Dawson J. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization. Fertil Steril 2001Apr;75(4): Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or invitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 2000 Jan 1;355(9197): Zayed F, Lenton E, Cooke I. Comparison between stimulated IVF & stimulated IUI for treatment of unexplained infertility & mild male factor infertility. Human Reprod 1997;12: Check JH, Spirito P. Higher pregnancy rates following treatment of cervical factor with intrauterine insemination without superovulation versus intercourse: the importance of a well-timed postcoital test for infertility. Arch Androl 1995 Jul-Aug;35(1): Lahteenmaki A, Veilahti J, Hovatta O. Intra-uterine insemination versus cyclic, low-dose prednisolone in couples with male antisperm antibodies. Hum Reprod 1995 Jan;10(1): Tummon IS, Asher LJ, Martin JS, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril 1997 Jul;68(1): Isaksson R, Tiitinen A. Superovulation combined with insemination or timed intercourse in the treatment of couples with unexplained infertility and minimal endometriosis. Acta Obstet Gynecol Scand 1997 Jul;76(6): Haebe J, Martin J, Tekpety F, Tummon I, Shepherd K. Success of IUI in women aged years. Fertil Steril 2002;78: Comment by: Aboubakr M. Elnashar, M.D. Department of Obstetrics and Gynecology Benha University Hospital, Egypt Cihat Unlu*, M.D. Batuhan Ozmen**, M.D. Ankara, Turkey Intrauterine insemination (IUI) with or without ovulation induction is a common treatment modality of assisted reproduction and most often offered to couples with at least one patent uterine tube. Main accepted indications for IUI are mildmoderate male infertility, infertility due to ovulation disorders, unexplained infertility and endometriosis. However it is still being a debate that these indications, especially for moderate male and unexplained infertility, are also similar to those for in-vitro fertilization (IVF) and indeed for intracytoplasmic sperm injection (ICSI). Subsequently this debate is arising some other controversial questions those recently indicated in a review of randomized studies on IUI (1); Is the patient referred specifically for IUI or other further treatments such as IVF? Do all practitioners and clinics have equal access to each technique? What influences the decision to have a particular cut-off for the one or the other, say for male factor? Another controversial point is the right timing of IUI in order to obtain a maximum chance for conception. The randomized trials studied on the timing of IUI after administration of human chorionic gonadotropin (hcg) or after spontaneous LH surge reveal also a great heterogeneity in both timing and ovulation induction protocols. It is commonly known that ovulation varies considerably and might also depend on the used ovulation induction protocols. Analysis of natural cycles by World Health Organization shown that ovulation mainly occurs within a mean time of 32 hours after the onset of LH surge ranging between hours (2). However in stimulated cycles ovulation usually occurs within hours and sequential over several hours from this interval after hcg administration (3). Besides spermatozoa survive and be able to fertilize only for a limited period in the female reproductive tract, and also oocytes are being fertilizable for only hours beginning 6 hours after ovulation. From this physiological point it can be considered as IUI success rates should decrease when it is not done in this specific interval. However apart from these data some oocytes can be fertilized as early as 12 hours after hcg administration with Clomiphene Citrate (CC) induction. Thus there are several articles in the literature indicated various timing for IUI leading the best clinical results ranging between hours. Moreover this interval is also varies according to detection of a spontaneous or a premature LH surge (which can occur in about 20%-25% of patients), resulting in ovulation within an average of hours, therefore IUI timing will need to be adjusted. Vol. 10, No. 1, 2005 Debate IUI for male factor and unexplained infertility 35
2 Therefore some different intervals have been reported for IUI leading the best chance for conception varies from to hours. A recent study poses that IUI either done in a short (32-34-hour) or long (38-40-hour) interval after hcg injection yields same pregnancy rates (PRs) (4). Furthermore timing of IUI and of ovulation with ultrasound monitoring of folliculogenesis along with hcg induction, a relatively expensive and time-consuming method, does not appear to produce an increased PR compared to monitoring of ovulation by urinary LH (5). In addition Arici et al. defined an increase in PR by triggering ovulation with hcg administration than cycles in which ovulation was monitored with urinary LH levels, however they compare CC stimulated versus non stimulated (6). A retrospective study of Awonuga et al, which compared the results of IUI after 40 hours from hcg administration and IUI after hours from detecting spontaneous LH surge with or without additional hcg administration in natural cycles and stimulated cycles, showed no statistical differences between three groups (7). They concluded that there is no additional benefit obtained from waiting spontaneous LH surge for timing of IUI in stimulated cycles. Thus hcg administration yields same PRs and also provides to planning the timing of IUI. More recently in a retrospective study Mitwally et al. also reported that hcg administration is associated with favorable outcome in ovulation induction (8). However, today the right time interval of IUI, the method of ovulation monitoring or triggering of ovulation with administration of hcg or not are still controversial. One can assume that this timing problem due to various intervals can be defeated by usage of double IUI performed in different time intervals in one cycle. Principal in this approach is to provide sufficient motile spermatozoa for in vivo fertilization regardless from ovulation time. However studies compared double and single IUI are also conflicts. An increase in the probability of achieving pregnancy with double IUI approach was noted in two previous studies (9,10). On contrary there are some recent reports failed to show any benefits of double IUI (11-13). In these studies most commonly double IUI performed at and hours assuming that first IUI provides a sufficient number of motile spermatozoa close to the first ovulated oocyte(s). The release of sperm from cervical mucus after the first IUI preceding to additional sperm provided by second IUI (34 hours) to fertilize the oocytes ovulated subsequently is the main principal for filling the complete ovulation window. A recent Cochrane review comparing double versus single IUI emphasized the necessity of high-quality randomized trials regarding heterogeneity of double IUI timing, various sperm preparation methods and different ovulation induction regimes with different drugs (13). The reviewers with available data indicated that there is no difference observed between double IUI and single IUI in clinical PRs (per couple or per cycle). However double IUI is also reported to increase PRs in some studies (9,10) and increase slightly the cost (10,11). Thus, it is still a common debate whether double IUI is efficient and also cost-effective or not? Another point is the double IUI role in moderate male infertility. One can assume that the second sperm sample, may be the most crucial one, could be of inferior quality and might not provide any benefit of double IUI in moderate male infertility. However the majority of the trials and the cochrane meta-analysis comparing double versus single IUI did not separately presented the results or the comparisons according to male factor. Except from these comparisons only Alborzi et al. (12) were mentioned the PRs in double IUI and single IUI as 4.7 % versus 7.8 % per cycle, and 22,2 % versus 16 % per couple in cases with male infertility. Thus one can speculate that double IUI performed in male infertility is reducing PRs however it was not found statistically different from single IUI results. Furthermore there is a major necessity of the studies on double IUI especially in male infertility cases. Besides there are also no certain accepted cut off values for the sperm counts and number of IUI cycles that should be performed mainly in male infertility particularly in unexplained infertility for single IUI. Therefore two main debates should also be considered. First, should there be new cut off values required for sperm counts when costeffectiveness is taken in consideration in male infertility cases?, and second, what should be the 36 Debate IUI for male factor and unexplained infertility MEFSJ
3 number of IUI cycles prior to IVF or further techniques in unexplained and male infertility cases again when cost-effectiveness is assumed? In order to answer the first and the second questions the prognostic values of sperm count values and diagnosis in IUI cycles should be kept in mind. It was reported that mean PRs for cycles 1-4 were significantly lower for patients with the following characteristics: age 43 years, poor semen quality, single preovulatory follicles, and diagnoses other than ovulatory dysfunction in CC induction (15). Therefore it was indicated in the same study that two additional cycles of CC-IUI after 3-4 cycles should be considered to compensate low PRs in cases with advanced partner age, poor semen quality and poor response but not for unexplained infertility. It was also reported that cumulative PRs reached to 43% after four CC-IUI cycles and to 57% after six CC-IUI cycles in male infertility with semen parameters below the WHO standards but met IUI threshold levels of 5 million total motile count and 30% progressive motility (15). However cumulative PRs are plateau at 10% after three CC-IUI cycles and no further pregnancies have been reported for the sperm quality lesser than mentioned IUI threshold levels (15). Ombelet (16) reported that patients with sub-threshold sperm values has a PR of 3.2 % per cycle and it seems logical to perform IUI in male infertility cases with inseminated motile sperm (IMSC) count of 1x106-5x106 and with normal morphology of 4-14 %. However in patients with IUI threshold values (< 5x106) other prognostic risk factors such as duration of infertility (less than 3 years), partners age (< 35) and other additional infertility diagnoses should be taken in consideration (17). In our opinion the patients with poor sperm quality under IUI threshold levels, but with good prognostic factors such as young partner age and short infertility duration (< 3 years) have chance to try six cycles due to compensation of PRs by two additional IUI cycle. On contrary it has been also reported that when the average total motile sperm count is under 10x106/ml, IVF with ICSI was more cost-effective than IUI suggesting an average total motile sperm count (TMSC) of 10x106/ml might be a useful threshold value for decisions about treating a couple with IUI or IVF (18). On contrary a total motile sperm count of 10x106/ml, and even lesser 5x106/ml have been reported to yield considerable PRs with a upper value of 12 % in a previous study (19). Therefore the exact cut-off values of sperm count especially for moderate male factor varies to define the technique in literature. Nevertheless threshold values of 5 or 10x106 TMSC in the ejaculate (19,20) and of 1x106 or 1.5x106 IMSC in the inseminate (16,21) have been reported in recent studies. Consequently we believe that the values of 1,5x106 or 5x106 IMSC according to other prognostic factors mentioned above should be taken as a threshold for IVF or further techniques. The second debate mentioned above is related with the efficacy of IUI and the maximum number of IUI cycles that should be performed in unexplained infertility. It has been concluded in a meta-analysis of Hughes et al.(22) that both IUI and stimulation of insemination cycles with follicle-stimulating hormone significantly improve fecundity independently in unexplained subfertility. In addition an ESHRE multicentre trial comparing the efficacy of other treatments versus IUI and IVF in idiopathic subfertility, indicated that IUI and IVF have increased chances of pregnancy compared with superovulation alone (23). Nevertheless neither IVF nor IUI was found to be superior to the other (23). However the common risk factors should be kept in mind such as the duration of infertility and the female partner age in patient selection to these treatments. Besides IUI along with controlled ovulation induction has been shown to be more cost-effective than IVF and associated with significantly lower costs per pregnancy resulting in at least one livebirth in unexplained and male infertility (24). A recent Cochrane meta-analysis indicated that until more evidence is available IVF may not be the preferred first line of treatment for these couples and it might be appropriate to continue with the less invasive options. Furthermore Aboulghar et al. (25) reported that patients should be offered IVF or ICSI who fail to conceive after three trials of COH (controlled ovarian hyperstimulation) and IUI the cycle fecundity in the first three trials of COH and IUI was higher statistically significant than in cycles 4-6. Consequently it has been clearly accepted that not for initial treatment but after 3 Vol. 10, No. 1, 2005 Debate IUI for male factor and unexplained infertility 37
4 COH and IUI cycles IVF should be performed in respect of other data. Conclusively we are in the beginning to define even the current role of IUI as well many technical innovations in assisted reproduction. Today many debates are ongoing to detect the right role of IUI especially on timing of IUI, triggering by hcg or waiting spontaneous LH surge, sperm IUI thresholds in male infertility, and the current role of IUI in unexplained infertility. Moreover to define the right role of IUI in assisted reproduction or to draw a firm conclusion we should have wealthier and clearer data. REFERENCES 1. Ian D. Cooke. Randomized studies in intrauterine insemination. Fertil Steril 2004; 82(1): World Health Organization, Temporal relationships between ovulation and defined changes in the concentration of plasma 17--estradiol, luteinizing hormone, follicle-stimulating hormone and progesterone. Am J Obstet Gynecol 1980;138: R.G. Edwards and P.C. Steptoe, Control of human ovulation, fertilization and implantation. Proc R Soc Med 1974; 67: P Claman, V Wilkie R.N, D Collins R.N. Timing intrauterine insemination either 33 or 39 hours after administration of human chorionic gonadotropin yields the same pregnancy rates as after superovulation therapy. Fertil Steril 2004; 82(1): TG Zreik, JA Garc?a-Velasco, MS Habboosh et al. Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles. Fertil Steril 1999; 71 (6): A. Arici, W. Byrd, K. Bradshaw, W.H. Kutteh, P. Marshburn and B.R. Carr, Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles. Fertil Steril 1994; 61: A. Awonuga, J Govindbhai. Is waiting for an endogenous LH surge and/or administration of hcg of benefit in intrauterine insemination. Hum Reprod 1999; 14(7): MF Mitwally, S Abdel-Razeq, RF Casper. Human Chorionic Gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination. Reprod Bio Endocrinol 2004, 2:55 doi: / Silverberg KM, Johnson JV, Olive DL, Burns WN and Schenken RS. A prospective, randomized trial comparing two different insemination regimens in controlled ovarian hyperstimulation cycles. Fertil Steril 1992; 57: Ragni G, Maggioni P, Guermandi E, Testa A, Baroni E, Colombo M et al., Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertil Steril 1999; 72: Ransom MX, Blotner MB, Boher M, Corsan G and Kemmann E. Does increasing frequency of intrauterine insemination improve pregnancy rates significantly during superovulation cycles? Fertil Steril 1994; 61: Alborzi S, Motazedian S, Parsanezhad ME and Jannati S. Comparison of the effectiveness of single intrauterine insemination (IUI) versus double insemination per cycle in infertile patients. Fertil Steril 2003; 80: Zeyneloglu HB, Bagis T, Lembet A, Ergin T, Kuscu E. Double intrauterine insemination (IUI) in clomiphene citrate (CC) cycles do not provide any advantage over single IUI: A randomized controlled trial. Fertil Steril 2002:S Cantineau AEP, Heineman MJ, Cohlen BJ. Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples. The Cochrane Database of Systematic Reviews,, Issue Dickey RP, Taylor SN, Lu PY, et al. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrateintrauterine insemination. Fertil Steril 2002; 78(5): Ombelet W. Semen Quality and intrauterine insemination. Reprod Med Online 2003, 7(1); Oehninger S. Pathopysiology of oligoasthenoteratozoospermia: are we improving in the diagnosis? Reprod Med Online 2003, 7(1); Van Voorhis BJ, Barnett M, Sparks AET, et al. Effect of the total motile sperm count on the efficacy and costeffectiveness of intrauterine insemination and in vitro fertilization. Fertil Steril, 2001; 75(4): Cohlen BJ, te Velde ER, van Kooij RJ, Looman CWN and Habbema JDF. Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Hum Reprod 1998; 13: Dickey RP, Pyrzak R, Lu PY, Taylor SN and Rye PH. Comparison of the sperm quality necessary for successful intrauterine insemination with World Health Organization threshold values for normal sperm. Fertil Steril 1999; 71: Campana A, Sakkas D, Stalberg A, Bianchi PG, Comte I, Pache T et al., Intrauterine insemination: evaluation of the results according to the women's age, sperm quality, total sperm count per insemination and life table analysis. Hum Reprod 1996;11: Hughes EG. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod 1997; 12: Crosignani PG, Walters DE and Soliani A. The ESHRE multicentre trial on the treatment of unexplained infertility: a preliminary report. European Society of Human Reproduction and Embryology. Hum Reprod, 1991; 6: Debate IUI for male factor and unexplained infertility MEFSJ
5 24. Goverde AJ, McDonnell J, Vermeiden JPW,et al. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. The Lancet 2000, 355; 9197: Pandian Z, Bhattacharya S, Nikolaou D, Vale L, Templeton A. In vitro fertilisation for unexplained subfertility (Cochrane Review). In: The Cochrane Library, Issue 4, Oxford: Update Software. Prof. Cihat Unlu, M.D. University of Ankara Faculty of Medicine Department of Obstetrics and Gynecology Reproductive Endocrinology Fax: ozmen_b@yahoo.com Batuhan Ozmen, M.D. University of Ankara Faculty of Medicine Reproductive Endocrinology and Research Center Comment by: Willem Ombelet, M.D., Ph.D. Genk, Belgium Approximately 10 to 15 % of women will receive infertility treatment during their lifetime and of all subfertile couples, only 1-2 % will undergo treatment with assisted reproductive technologies (ART). Artificial insemination with husband's semen (AIH) has been used in clinical medicine for more than 200 years in the treatment of infertile couples. The first documented application of AIH was done in London in the 1770s by John Hunter. A patient with severe hypospadias was advised to collect the semen ( which escaped during coitus ) in a warmed syringe and inject the sample into the vagina. J.M.Sims reported his findings of postcoital tests and 55 inseminations in the mid 1800s but only after the introduction of sperm donation artificial insemination became very popular. For many years homologous artificial inseminations were only indicated in cases of physiologic and psychologic dysfunction, such as retrograde ejaculation, vaginismus, hypospadias and impotence. With the routine use of post-coital tests other indications were added such as hostile cervical mucus and immunologic causes with the presence of antispermatozoal antibodies in the cervical mucus. The term AIH covers a wide range of different techniques. Washed or unwashed semen can be used and inseminated at various levels in the female reproductive tract. The insemination can be done intravaginally, intracervically, pericervically using a cap, intrauterine, intratubal or directly intraperitoneal. Most studies refer to intrauterine inseminations (IUI) which seems to be an easy and better way of treatment. The rationale for the therapy of artificial insemination is the increase of gamete density at the site of fertilization. The theoretic advantage of IUI over intravaginal techniques may be due to the increasing number of sperm arriving at the fertilization site, even when sperm or cervical mucus abnormalities are present. The increasing use of AIH in idiopathic and male infertility is mainly the result of the refinement of techniques for the preparation of washed motile spermatozoa as they were used in IVF procedures, finally resulting in a post-wash fraction containing a high number of motile spermatozoa with a better sperm morphology. For ART, success in subfertility treatment is generally described as pregnancy rate per treatment cycle (IVF, ICSI, IUI). On the other hand, it is important to be aware of the complex weave of secondary issues to consider such as neonatal outcome, short and long term infant morbidity and maternal complications, all of them closely linked to the higher incidence of multiple pregnancies after treatment with assisted reproductive techniques. Consequently, ART (especially IVF and ICSI) accounts for % of the total health care costs in the USA compared to % in the Nordic countries. This can only be explained by the lower incidence of multiples in Scandinavian countries. When male subfertility is found in couples with longstanding infertility, IVF and ICSI are not the only treatment options. From a theoretic point of view, increasing the number of motile spermatozoa at the site of fertilization with intrauterine insemination, especially when sperm quality is suboptimal, should increase the probability of conception. In two meta-analyses, Cohlen et al (1) Vol. 10, No. 1, 2005 Debate IUI for male factor and unexplained infertility 39
Assessment of the value of ultrasound monitoring and doubling of insemination in clomiphene citrate stimulated IUI cycles
Middle East Fertility Society Journal Vol. 9, No. 1, 2004 Copyright Middle East Fertility Society Assessment of the value of ultrasound monitoring and doubling of insemination in clomiphene citrate stimulated
More informationComparison of the effectiveness of single intrauterine insemination (IUI) versus double IUI per cycle in infertile patients
FERTILITY AND STERILITY VOL. 80, NO. 3, SEPTEMBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Comparison of the effectiveness
More informationComparison of single versus double intra uterine insemination
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pathak B. Int J Reprod Contracept Obstet Gynecol. 2017 Dec;6(12):5277-5281 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20175091
More informationAssisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION
( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation
More informationCOMPARISON OF SINGLE VERSUS DOUBLE INTRAUTERINE INSEMINATION
ORIGINAL ARTICLE COMPARISON OF SINGLE VERSUS DOUBLE INTRAUTERINE INSEMINATION Kazım Gezginç*, Hüseyin Görkemli, Çetin Çelik, Rengin Karatayli, M. Nedim Çiçek, M. Cengiz Çolakoglu Department of Obstetrics
More informationClomiphene citrate monitoring for intrauterine insemination timing: a randomized trial
OVULATION INDUCTION Clomiphene citrate monitoring for intrauterine insemination timing: a randomized trial Vivian Lewis, M.D., a John Queenan Jr., M.D., a Kathleen Hoeger, M.D., a Joanne Stevens, R.N.,
More informationThe evidence for insemination versus intercourse or IVF
To inseminate or not: that s the question! The evidence for insemination versus intercourse or IVF B.Cohlen, Genk 2009 There are believers and non-believers Ovarian stimulation protocols (anti-oestrogens,
More informationResearch and Health Policy Studies, Tufts-New England Medical Center, Boston, Massachusetts
Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis Ioannis P. Kosmas, M.D., a Athina
More informationSubfertility & prognostic factors & intrauterine insemination
Subfertility & prognostic factors & intrauterine insemination N.Cem FIÇICIOĞLU, M.D., Ph.D. Professor and Director Department of Gynecology & Obstetrics and IVF Center Yeditepe University, School of Medicine
More informationClinical Study Fallopian Tube Sperm Perfusion in Treatment of Nontubal Subfertility: Is It Crucial Step prior to ART?
International Scholarly Research Network ISRN Obstetrics and Gynecology Volume 2011, Article ID 160467, 4 pages doi:10.5402/2011/160467 Clinical Study Fallopian Tube Sperm Perfusion in Treatment of Nontubal
More informationControlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study
Human Reproduction vol.13 no.6 pp.1553 1558, 1998 Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study Bernard J.Cohlen 1,3, Egbert R.te
More informationControlled Ovarian Hyperstimulation with Intrauterine Insemination Is More Successful After r-hcg Administration Than Spontaneous LH Surge
Original Article Controlled Ovarian Hyperstimulation with Intrauterine Insemination Is More Successful After r-hcg Administration Than Spontaneous LH Surge Evan Taerk, Edward Hughes, Cassandra Greenberg,
More informationDouble versus single intrauterine insemination for unexplained infertility: a meta-analysis of randomized trials
Double versus single intrauterine insemination for unexplained infertility: a meta-analysis of randomized trials Nikolaos P. Polyzos, M.D., a Spyridon Tzioras, M.D., Ph.D., a Davide Mauri, M.D., Ph.D.,
More informationFactors determining successful intrauterine insemination
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Sinha P et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):3887-3891 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174028
More informationUnexplained Infertility
Unexplained Infertility Kaylen M. Silverberg, M.D. Thomas C. Vaughn, M.D. Texas Fertility Center Austin, Texas Introduction Infertility is generally defined as the inability to conceive following one year
More informationLow Dose hmg As a First choice for Ovarian Stimulation in IUI cycles
Low Dose hmg As a First choice for Ovarian Stimulation in IUI cycles aslan, M.D Department of Obstetrics & Gynecology, Cairo University Abstract Objective: to compare pregnancy rates following low dose
More informationREPRODUCTIVE ENDOCRINOLOGY
REPRODUCTIVE ENDOCRINOLOGY FERTILITY AND STERILITY VOL. 81, NO. 5, MAY 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Analysis
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationSubfertility B Y A L I S O N, B E N A N D J O H N
Subfertility B Y A L I S O N, B E N A N D J O H N Contents Definition Causes Male Female Hx & Ex Investigations Treatment Definition Failure to conceive after a year of frequent, unprotected communion.
More informationEffect of semen characteristics on pregnancy rate following intrauterine insemination
127 ORIGINAL Effect of semen characteristics on pregnancy rate following intrauterine insemination Uranchimeg Dorjpurev, Akira Kuwahara, Yuya Yano, Tomoko Taniguchi, Yuri Yamamoto, Ayako Suto, Yu Tanaka,
More informationNICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic
NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationDecoding the effect of time interval between hcg and IUI and sperm preparation and IUI
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Agrawal S et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):892-896 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180509
More informationOriginal Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2
Original Article Comparison of Letrozole and Clomiphene Citrate Efficacy along with Gonadotrophins in Controlled Ovarian Hyperstimulation for Intrauterine Insemination Cycles Fauzia HaqNawaz 1*, Saadia
More informationThe prognostic factors for pregnancy after gonadotropin-induced controlled ovarian stimulation therapy with intrauterine insemination cycles
Available online at www.medicinescience.org ORIGINAL RESEARCH Medicine Science International Medical Journal Medicine Science 2018; ( ): The prognostic factors for pregnancy after gonadotropin-induced
More informationInfertility. Thomas Lloyd and Samera Dean
Infertility Thomas Lloyd and Samera Dean Infertility Definition Causes Referral criteria Assisted reproductive techniques Complications Ethics What is infertility? Woman Reproductive age Has not conceived
More informationUse of donor semen in the treatment of
Use of donor semen in the treatment of male infertility Where is the evidence? Max H.J.M. Curfs Isala clinics Zwolle, The Netherlands Strength of evidence Systematic review Meta-analysis RCT 1A 1A 1B
More informationCLINICAL ASSISTED REPRODUCTION
Journal of Assisted Reproduction and Genetics, Vol. 17, No. 4. 2000 CLINICAL ASSISTED REPRODUCTION CLINICAL ASSISTED REPRODUCTION Effect of Clinical and Semen Characteristics on Efficacy of Ovulatory Stimulation
More informationWhich is the Best Protocol of Ovarian Stimulation Prior to Artificial Insemination by Donor
Journal of Reproduction & Contraception doi: 10.7669j.issn.1001-7844.2014.01.0041 2014 Mar.; 25(1):41-48 E-mail: randc_journal@163.com Which is the Best Protocol of Ovarian Stimulation Prior to Artificial
More informationUnexplained infertility Evidence based management
Unexplained infertility Evidence based management Dr Mark Hamilton Consultant Gynaecologist NHS Grampian/University of Aberdeen m.hamilton@abdn.ac.uk www.iffs-reproduction.org @IntFertilitySoc Int@FedFertilitySoc
More informationIntrauterine Insemination - FAQs Q. How Does Pregnancy Occur?
Published on: 8 Apr 2013 Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur? A. The female reproductive system involves the uterus, ovaries, fallopian tubes, cervix and vagina. The female hormones,
More informationUvA-DARE (Digital Academic Repository) Cost-effectiveness in reproductive medicine Moolenaar, L.M. Link to publication
UvA-DARE (Digital Academic Repository) Cost-effectiveness in reproductive medicine Moolenaar, L.M. Link to publication Citation for published version (APA): Moolenaar, L. M. (2013). Cost-effectiveness
More informationIUI or IVF: In Resource Crunch Countries
Short Communication www.jbcrs.org IUI or IVF: In Resource Crunch Countries Bindu Bajaj* Department of Obstetrics and Gynaecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
More informationArticle Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination
RBMOnline - Vol 13. No 2. 2006 208-212 Reproductive BioMedicine Online; www.rbmonline.com/article/2334 on web 30 May 2006 Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine
More informationIndian Journal of Basic and Applied Medical Research; September 2015: Vol.-4, Issue- 4, P
Original article: To study post intrauterine insemination conception rate among infertile women with polyp and women with normal uterine endometrium cavity 1Dr. Archana Meena, 2 Dr. Renu Meena, 3 Dr. Kusum
More informationInternational Federation of Fertility Societies. Global Standards of Infertility Care
International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationRelation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy
Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Aseel Mosa Jabber M.SC.G.O. The department of Obstetrics and Gynecology, Faculty of Medicine Thi-qar university
More informationSynchronised approach for intrauterine insemination in subfertile couples Cantineau, Astrid E. P.; Janssen, Mirjam J.; Cohlen, Ben J.
University of Groningen Synchronised approach for intrauterine insemination in subfertile couples Cantineau, Astrid E. P.; Janssen, Mirjam J.; Cohlen, Ben J. Published in: Cochrane Database of Systematic
More informationK.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1
Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and
More informationSubject: Infertility Policy Effective Date: 01/07 Revision Date: 01/2018
Subject: Infertility Policy Effective Date: 01/07 Revision Date: 01/2018 DESCRIPTION Infertility is the condition of an individual who has been unable to conceive or produce conception during a period
More informationOne versus two inseminations per cycle in intrauterine insemination with sperm from patients husbands: a systematic review of the literature
FERTILITY AND STERILITY VOL. 82, NO. 1, JULY 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. One versus two inseminations
More informationIs the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion
F, V & V IN OBGYN, 2010, MONOGRAPH: 36-41 Artificial insemination Is the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion Arne SUNDE 1, Jarl
More informationSperm Surface Antibodies: IUI vs. IVF Treatment
Research Article Sperm Surface Antibodies: IUI vs. IVF Treatment Afaf Felemban MD*, Seham M. Hassonah MD, Najla Felimban KD, Hadeel Alkhelb MD, Samar Hassan MD, Fahad Alsalman MD Department of Obstetrics
More informationKeywords: annual reports, international literature, intrauterine insemination, multiple pregnancy, ongoing pregnancy, The Netherlands
RBMOnline - Vol 14. No 1. 2007 110-116 Reproductive BioMedicine Online; www.rbmonline.com/article/2440 on web 23 November 2006 The aim of this retrospective study was to assess the results of intrauterine
More informationRBMOnline - Vol 15. No Reproductive BioMedicine Online; on web 31 July 2007
RBMOnline - Vol 15. No 4. 2007 422-427 Reproductive BioMedicine Online; www.rbmonline.com/article/2861 on web 31 July 2007 Patients preferences for intrauterine insemination (IUI) relative to IVF were
More informationFactors affecting success of intrauterine insemination: a 3 year prospective study
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Jayakrishnan K et al. Int J Reprod Contracept Obstet Gynecol. 2016 Apr;5(4):1077-1083 www.ijrcog.org pissn 2320-1770 eissn
More informationMale subfertility and assisted reproduction: the quest for the ultimate treatment strategy van Weert, J-M.
UvA-DARE (Digital Academic Repository) Male subfertility and assisted reproduction: the quest for the ultimate treatment strategy van Weert, J-M. Link to publication Citation for published version (APA):
More informationThe place of intrauterine insemination in the management of infertility
CURRENT PAPERS Keywords control led ovarian hyperstimulation (COH), intrauterine insemination (IUI), in witro fertilisation (IVF), male factor i n f e rt i I it y, su bfert i I ity. The place of intrauterine
More informationComparision of Letrozole with Timed Intercourse Versus Clomiphene Citrate with Intrauterine Insemination in Patients with Unexplained Infertility
The Journal of Reproductive Medicine Comparision of Letrozole with Timed Intercourse Versus Clomiphene Citrate with Intrauterine Insemination in Patients with Unexplained Infertility Jorge Rodriguez-Purata,
More informationInformation Booklet. Exploring the causes of infertility and treatment options.
Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole
More informationPredictive Factors for Pregnancy after Intrauterine Insemination: A Retrospective Study of Factors Affecting Outcome
Azadeh Pravin Patel et al Original Article 10.5005/jp-journals-10006-1404 Predictive Factors for Pregnancy after Intrauterine Insemination: A Retrospective Study of Factors Affecting Outcome 1 Azadeh Pravin
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationART Drugs. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.02 Subject: ART Drugs Page: 1 of 7 Last Review Date: September 15, 2017 ART Drugs Description Bravelle
More informationJournal of American Science 2013;9(12) Mohamed Elkadi, Amr Elhelaly, Ahmed Ibrahim, Shereen Abdelaziz
Clomiphene Citrate Alone or Followed by Human Chorionic Gonadotropin In Induction of Ovulation. Mohamed Elkadi, Amr Elhelaly, Ahmed Ibrahim, Shereen Abdelaziz Department of Obstetrics and Gynecology Ain
More informationJMSCR Vol 04 Issue 12 Page December 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.77 Clinical Pregnancy Rate in Intra Uterine
More informationIntrauterine insemination treatment in subfertility: an analysis of factors affecting outcome
Human Reproduction vol.14 no.3 pp.698 703, 1999 Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome Sinikka Nuojua-Huttunen 1,4, Candido Tomas 2, Risto Bloigu
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationMinimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S
Minimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S Record Status This is a critical abstract of an economic
More informationReview Article The Potential Use of Intrauterine Insemination as a Basic Option for Infertility: A Review for Technology-Limited Medical Settings
Obstetrics and Gynecology International Volume 2009, Article ID 584837, 11 pages doi:10.1155/2009/584837 Review Article The Potential Use of Intrauterine Insemination as a Basic Option for Infertility:
More informationBleeding and spontaneous abortion after therapy for infertility
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Bleeding and spontaneous
More informationComparison of the success rate of letrozole and clomiphene citrate. in women undergoing intrauterine insemination
Received: 10.2.2006 Accepted: 8.11.2006 Original Article Comparison of the success rate of letrozole and clomiphene citrate in women undergoing intrauterine insemination Robab Davar*, Maryam Asgharnia
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More informationART Drugs. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.02 Subject: ART Drugs Page: 1 of 7 Last Review Date: December 3, 2015 ART Drugs Description Bravelle
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationInfertility: A Generalist s Perspective
Infertility: A Generalist s Perspective Learning Objectives Fertility and Lifestyle: Patient education Describe the basic infertility workup Basic treatment strategies unexplained Heather Huddleston, MD
More informationCurrent Evidence On Infertility Treatment
Current Evidence On Infertility Treatment Mahmoud A.M. Abdel-Aleem Regina Kulier WHO/GFMER 2003 Problem of Infertility It is a state in which a couple, desirous of a child, cannot conceive after 12 months
More informationEDITOR S PICK INTRAUTERINE INSEMINATION: CURRENT PLACE IN INFERTILITY MANAGEMENT. *Shikha Jain
EDITOR S PICK My Editor s Pick for this issue, by Jain, provides a thorough review into intrauterine insemination s role in infertility management. It is essential to clarify the range of indications for
More informationChapter 1. Chapter 2. Chapter 3
Summary To perform IUI some conditions are required. This includes 1) a certain amount of progressively motile spermatozoa, 2) the presence of ovulation, 3) the presence of functional fallopian tubes,
More informationA.J.Goverde 1,2,3, C.B.Lambalk 1, J.McDonnell 1, R.Schats 1, R.Homburg 1 and J.P.W.Vermeiden 1
Human Reproduction Vol.20, No.11 pp. 3141 3146, 2005 Advance Access publication July 21, 2005. doi:10.1093/humrep/dei175 Further considerations on natural or mild hyperstimulation cycles for intrauterine
More informationTime to improvement in semen parameters after microsurgical varicocelectomy in men with severe oligospermia
Time to improvement in semen parameters after microsurgical varicocelectomy in men with severe oligospermia Thomas A. Masterson; Aubrey B. Greer; Ranjith Ramasamy University of Miami, Miami, FL, United
More informationBlackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception
1 Introduction Blackpool CCG Policies for the Commissioning of Healthcare Assisted Conception 1.1 This policy describes circumstances in which NHS Blackpool Clinical Commissioning Group (CCG) will fund
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationCommon protocols in intra-uterine insemination cycles
Common protocols in intra-uterine insemination cycles Doç. Dr. Candan İltemir Duvan Turgut Özal Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum AD Ovulation induction with intra-uterine insemination
More informationInfertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?
Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.
More informationAssisted Reproductive Technology (ART) / Infertility / Synarel (nafarelin)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.03 Subject: Synarel Page: 1 of 5 Last Review Date: September 15, 2016 Synarel Description Assisted
More informationF.Zayed 1 ' 3, E.A.Lenton 1 ' 2 and I.D.Cooke 2
Human Reproduction vol.12 no. 11 pp.2408-2413, 1997 Comparison between stimulated in-vitro fertilization and stimulated intrauterine insemination for the treatment of unexplained and mild male factor infertility
More informationThe length of the fertile window is associated with the chance of spontaneously conceiving an ongoing pregnancy in subfertile couples
Human Reproduction Vol.22, No.6 pp. 1652 1656, 2007 Advance Access publication on April 20, 2007 doi:10.1093/humrep/dem051 The length of the fertile window is associated with the chance of spontaneously
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationIntrauterine insemination, what do we really know? A critical appraisal of the literature
F, V & V IN OBGYN, 2010, MONOGRAPH: 1328 Artificial insemination Intrauterine insemination, what do we really know? A critical appraisal of the literature Pieternel STEURES 1,2,3, Jan Willem VAN DER STEEG
More informationClinical Policy Committee
Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments
More informationNew York Science Journal 2014;7(4)
The Minimal Stimulation Protocol for ICSI: An Alternative Protocol for Ovarian Stimulation Adel Elsayed Ibrahim, MD Assisted Reproductive Unit Azhar University Adel.sayed29@gmail.com Abstract: Background:
More informationRecommended Interim Policy Statement 150: Assisted Conception Services
Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations
More informationClinical Policy Committee
Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year
More informationUvA-DARE (Digital Academic Repository) Intrauterine insemination: Fine-tuning a treatment Custers, I.M. Link to publication
UvA-DARE (Digital Academic Repository) Intrauterine insemination: Fine-tuning a treatment Custers, I.M. Link to publication Citation for published version (APA): Custers, I. M. (013). Intrauterine insemination:
More informationPolicy statement. Fertility treatments. This policy is unchanged from the version approved by the CCG in July 2014.
Policy statement Fertility treatments This policy is unchanged from the version approved by the CCG in July 2014. Title Policy statement: Fertility treatments v2.0 Author Jacky Walters Approved by Kingston
More informationIntra uterine insemination (IUI) Information for Patients and Partners
Intra uterine insemination (IUI) Information for Patients and Partners What is this leaflet about and who is it for? This leaflet is produced to inform couples undergoing IUI (intrauterine insemination)
More information5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle
Infertility FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology I AM RECEIVING COMPENSATION
More informationThe Use of Gonadotropin Releasing Hormone Antagonist in Women Undergoing Intrauterine Insemination
Research Article imedpub Journals http://www.imedpub.com/ DOI: 10.21767/1989-5216.1000263 ARCHIVES OF MEDICINE The Use of Gonadotropin Releasing Hormone Antagonist in Women Undergoing Intrauterine Insemination
More informationLetrozole versus Clomiphene Citrate in Patients with Anovulatory Infertility
South Asian Letrozole Federation versus of Clomiphene Obstetrics Citrate and Gynecology, in Patients with January-April Anovulatory Infertility 2009;1(1):19-23 ORIGINAL STUDIES Letrozole versus Clomiphene
More informationAdvanced semen analysis: a simple screening test to predict intrauterine insemination success
FERTILITY AND STERILITY VOL. 71, NO. 3, MARCH 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Advanced semen analysis:
More informationASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE
ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationLong-term ongoing pregnancy rate and mode of conception after a positive and negative post-coital test
A C TA Obstetricia et Gynecologica AOGS MAIN RESEARCH ARTICLE Long-term ongoing pregnancy rate and mode of conception after a positive and negative post-coital test MARLOES HESSEL 1,2, MONIQUE BRANDES
More informationThe predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt*
FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. The predictive value of idiopathic failure to fertilize on the first in vitro fertilization
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More informationSt Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16
St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review
More informationCriteria for NHS Funded Assisted Conception Treatments for Sub-fertility For CCGs within East Sussex
Criteria for NHS Funded Assisted Conception Treatments for Sub-fertility For CCGs within East Sussex 1 Title Ref No Document objective Audience Dissemination Document Details Criteria for NHS Funded Assisted
More informationMinimal monitoring / Minimal stimulation as a means of increasing access to ART in developing countries
Minimal monitoring / Minimal stimulation as a means of increasing access to ART in developing countries Willem Ombelet Genk Institute for Fertility Technology Maribor, 27-02-09 Third World = overpopulation
More information